Jasmine Luzum

Assistant Professor

University of Michigan

United States

Research Interests

Explore related searches

Professors in United States Professors in Medical Science Medical Science professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jasmine Luzum is an Assistant Professor at the University of Michigan in the United States. Her research focuses on cardiovascular health, particularly in areas such as genetic testing for cardiovascular disease, drug interactions in therapy, and the role of metabolites in heart failure. She has contributed to several significant publications addressing pharmacogenomics and its application in clinical practice.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (11)

Yimei Huang

Courtesy Clinical Assistant Professor

University of Florida

UNITED STATES

View details

Craig Lee

University of North Carolina at Chapel Hill

UNITED STATES

View details

Sony Tuteja

Assistant Professor

University of Pennsylvania

UNITED STATES

View details

Glenda Hoffecker

University of Pennsylvania

UNITED STATES

View details

Alessandra M Campos-Staffico

Assistant Professor

Creighton University

UNITED STATES

View details

Jordan Baye

Assistant Professor

UNITED STATES

View details

Robert Dess

University of Michigan

UNITED STATES

View details

Julio Duarte

University of Florida

UNITED STATES

View details

Andrea Gaedigk

UNITED STATES

View details

D. Max Smith

Assistant Professor

Georgetown University Medical Center

UNITED STATES

View details

Snezana Kusljic

Associate Professor

University of Melbourne

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jasmine Luzum

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Direct-to-Consumer Genetic Testing for Cardiovascular Disease: A Scientific Statement From the American Heart Association.

Association of plasma metabolites and cardiac mitochondrial function with heart failure progression.

Factors Associated With the Recovery of Left Ventricular Ejection Fraction in Patients With Anthracycline-Induced Left Ventricular Dysfunction.

It is time for educators to act: pharmacogenomics education and its implementation into clinical practice

Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta‐Blocker Therapy

Managing drug-drug interactions with mavacamten: A focus on combined use of antiarrhythmic drugs and anticoagulants.

Equal Treatment, Unequal Outcomes? Debunking the Racial Disparity in Renin Angiotensin Aldosterone System Inhibitor-Associated Reduction in Heart Failure Hospitalizations.

Polygenic risk score for drug-induced long QT syndrome: independent validation in a real-world patient cohort.

Genetic drivers of human plasma metabolites that determine mortality in heart failure patients with reduced ejection fraction.

<i>CYP2C19</i> Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart Association.

An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare Providers

Evaluation of a New Aptamer-Based Array for Soluble Suppressor of Tumorgenicity (ST2) and N-terminal Pro-B-Type Natriuretic Peptide (NTproBNP) in Heart Failure Patients.

Validation of a Polygenic Score for Beta-Blocker Survival Benefit in Patients With Heart Failure Using the United Kingdom Biobank.

ASSOCIATION OF PLASMA METABOLITES AND CARDIAC MITOCHONDRIAL FUNCTION WITH HEART FAILURE PROGRESSION

Eight pharmacokinetic genetic variants are not associated with the risk of bleeding from direct oral anticoagulants in non-valvular atrial fibrillation patients.

Abstract 14037: Nonspecific Tools Performed Better in Discriminating Major Bleeding From Direct Oral Anticoagulants Than Specific Tools in a Real-World Population With Atrial Fibrillation

Abstract 14063: Eight Pharmacokinetic-Related Genetic Variants Were Not Associated With Bleeding From Direct Oral Anticoagulants in Non-Valvular Atrial Fibrillation Patients

Pharmacogenetics of Antiplatelet Therapy.

Polygenic Risk Scores for Cardiovascular Disease: A Scientific Statement From the American Heart Association.

The genetics of drug-induced QT prolongation: evaluating the evidence for pharmacodynamic variants.

Collaborators (11)

Yimei Huang

Craig Lee

Sony Tuteja

Glenda Hoffecker

Alessandra M Campos-Staffico

Jordan Baye

Robert Dess

Julio Duarte

Andrea Gaedigk

D. Max Smith

Snezana Kusljic

Make your next move.